Cited by 192Systemic Lupus Erythematosus ResearchAdrenal Hormones and DisordersSystemic Sclerosis and Related Diseases

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Dehydroepiandrosterone in systemic lupus erythematosus

Van Vollenhoven, Ronald F., Engleman, Edgar G., Mcguire, James L.·1995·Arthritis & Rheumatism

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To determine if dehydroepiandrosterone (DHEA) is beneficial in the treatment of systemic lupus erythematosus (SLE). METHODS: In a double-blind, placebo-controlled, randomized trial, 28 female patients with mild to moderate SLE were given DHEA 200 mg/day or placebo for 3 months. Outcomes included the SLE Disease Activity Index (SLEDAI) score, patient's and physician's overall assessments of disease activity, and concurrent corticosteroid dosages (which were adjusted as clinically indicated). RESULTS: In the patients who were receiving DHEA, the SLEDAI score, patient's and physician's overall assessment of disease activity, and concurrent prednisone dosage decreased, while in the patients taking placebo, small increases were seen. The difference in patient's assessment between the groups was statistically significant (P = 0.022, adjusted). Lupus flares occurred more frequently in the placebo group (P = 0.053). Mild acne was a frequent side effect of DHEA. CONCLUSION: DHEA may be useful as a therapeutic agent for the treatment of mild to moderate SLE. Further studies of DHEA in the treatment of SLE are warranted.

Integrity signals

Registry

Crossref · 10.1002/art.1780381216

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).
Linker‐Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S. J., Gillis, S. A., & Horwitz, D. A. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2651 · Cited by 453
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110579 · Cited by 422
Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experience
Petri, M., Howard, D., & Repke, J. T. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341210 · Cited by 392
Physiological importance of dehydroepiandrosterone.
Eberling, P., & Koivisto, V. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92587-9 · Cited by 365
An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use
Belongia, E. A., Hedberg, C. W., Gleich, G. J., White, K. E., Mayeno, A. N., Loegering, D. A., Dunnette, S. L., Pirie, P. L., MacDonald, K. L., & Osterholm, M. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008093230601 · Cited by 356
Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function.
Daynes, R. A., Araneo, B. A., Dowell, T., Huang, K. L., & Dudley, D. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.979 · Cited by 341
Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.
Steinberg, A. D., Roths, J. B., Murphy, E. D., Steinberg, R. T., & Raveche, E. S. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.2.871 · Cited by 326

Flagged first, then by citations

Show all 36 references

1 of the 36 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Felt V, 1966, Metabolic effects of DHEA and atromid in patients with hyperlipaemia, Cor Vasa, 8, 40

Sorted by citations

Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
DHEA and DHEA‐S: A Review
Kroboth, P. D., Salek, F. S., Pittenger, A. L., Fabian, T. J., & Frye, R. F. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007903 · Cited by 530
Understanding how we age: insights into inflammaging
Baylis, D., Bartlett, D. B., Patel, H. P., & Roberts, H. C. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-8 · Cited by 413
Serum Dehydroepiandrosterone (DHEA) and DHEA Sulfate Are Negatively Correlated with Serum Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence and Immunosenescence
Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4876 · Cited by 351
Guidelines for referral and management of systemic lupus erythematosus in adults
Wolfe, F., & Pincus, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9 · Cited by 269
Systemic lupus erythematosus
Ruiz‐Irastorza, G., Khamashta, M. A., Castellino, G., & Hughes, G. R. V. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04239-2 · Cited by 265
Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 243
Neural immune pathways and their connection to inflammatory diseases.
Eskandari, F., Webster, J. I., & Sternberg, E. M. (2003) · Arthritis Research · doi:10.1186/ar1002 · Cited by 201
Systemic lupus erythematosus in childhood
Klein‐Gitelman, M., Reiff, A. O., & Silverman, E. D. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(02)00015-7 · Cited by 198
DHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 187
Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand, V., Gladman, D. D., Isenberg, D. A., Petri, M., Smolen, J. S., & Tugwell, P. (1999) · PubMed · Cited by 179
Sex hormones and systemic lupus erythematosus: Review and meta‐analysis
McMurray, R. W., & May, W. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11105 · Cited by 172
Dehydroepiandrosterone treatment of women with mild‐to‐moderate systemic lupus erythematosus: A multicenter randomized, double‐blind, placebo‐controlled trial
Chang, D., Lan, J., Lin, H., & Luo, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10615 · Cited by 164
Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
CASTAGNETTA, L. A. M., Carruba, G., Granata, O. M., Stefano, R., Miele, M., Schmidt, M., Cutolo, M., & Straub, R. H. (2003) · PubMed · Cited by 160
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial
Petri, M., Lahita, R. G., van Vollenhoven, R., Merrill, J. T., Schiff, M. H., Ginzler, E. M., Strand, V., Kunz, A. Y., Gorelick, K. J., & Schwartz, K. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10364 · Cited by 154
DHEA treatment: myth or reality?
Allolio, B., & Arlt, W. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00617-3 · Cited by 153
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus
Petri, M., Mease, P. J., Merrill, J. T., Lahita, R. G., Iannini, M. J., Yocum, D. E., Ginzler, E. M., Katz, R. S., Gluck, O. S., Genovese, M. C., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20427 · Cited by 144
A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
van Vollenhoven, R. F., Park, J. L., Genovese, M. C., West, J. P., & McGuire, J. L. (1999) · Lupus · doi:10.1191/096120399678847588 · Cited by 144
Self-citation
Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion
Arlt, W., Callies, F., Koehler, I., van Vlijmen, J. C., Faßnacht, M., Strasburger, C. J., Seibel, M. J., Huebler, D., Ernst, M. E., Oettel, M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7974 · Cited by 139
DHEAS Deficiency During Consumption of Sustained-Action Prescribed Opioids: Evidence for Opioid-Induced Inhibition of Adrenal Androgen Production
Daniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 140
Hormonal modulation of B cell development and repertoire selection
Grimaldi, C. M., Hill, L., Xu, X., Peeva, E., & Diamond, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.014 · Cited by 122
Lupus arthritis
Grossman, J. M. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.04.003 · Cited by 122
Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease
Straub, R. H., Vogl, D., Gross, V., Lang, B., Schölmerich, J., & Andus, T. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00535.x · Cited by 114
Hormones and immune function: implications of aging
Arlt, W., & Hewison, M. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00109.x · Cited by 110
The process of aging changes the interplay of the immune, endocrine and nervous systems
Straub, R. H., Cutolo, M., Zietz, B., & Schölmerich, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00289-5 · Cited by 110
Dehydroepiandrosterone and ageing
Arlt, W. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.02.006 · Cited by 108
Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial
Hartkamp, A., Geenen, R., Godaert, G. L. R., Bootsma, H., Kruize, A. A., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071563 · Cited by 104
GENETICS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Sullivan, K. E. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70137-x · Cited by 89
Androgen therapy with dehydroepiandrosterone
Buvat, J. (2003) · World Journal of Urology · doi:10.1007/s00345-003-0367-7 · Cited by 87
Longitudinal changes in dehydroepiandrosterone concentrations in men and women
Nafziger, A. N., Bowlin, S. J., Jenkins, P. L., & Pearson, T. A. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90181-0 · Cited by 82
Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock
Arlt, W., Hammer, F., Sanning, P., Butcher, S. K., Lord, J. M., Allolio, B., Annane, D., & Stewart, P. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2258 · Cited by 82
High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis
Straub, R. H., Zeuner, M., Lock, G., Schölmerich, J., & Lang, B. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.4.426 · Cited by 76
Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice
Yang, L.-Y., Chen, A., Kuo, Y., & Lin, C.-Y. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90171-3 · Cited by 74
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus
Cutolo, M., Sulli, A., Villaggio, B., SERIOLO, B., & Accardo, S. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.10.573 · Cited by 74
Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus
Nordmark, G., Bengtsson, C., Larsson, A. O., Karlsson, F. A., Sturfelt, G. K., & Rönnblom, L. (2005) · Autoimmunity · doi:10.1080/08916930500285550 · Cited by 70
A critical review of clinical trials in systemic lupus erythematosus
Mahieu, M. A., Strand, V., Simon, L. S., Lipsky, P. E., & Ramsey‐Goldman, R. (2016) · Lupus · doi:10.1177/0961203316652492 · Cited by 71
Lupus erythematosus and nutrition: A review of the literature
Brown, A. C. (2000) · Journal of Renal Nutrition · doi:10.1053/jren.2000.16323 · Cited by 68
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly?
Genazzani, A. D., Lanzoni, C., & Genazzani, A. R. (2007) · Drugs & Aging · doi:10.2165/00002512-200724030-00001 · Cited by 69
Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor
Straub, R. H., Lehle, K., Herfarth, H. H., Weber, M., Falk, W., Preuner, J. G., & Schölmerich, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460365 · Cited by 67
Uses of DHEA in aging and other disease states
JOHNSON, M., Bebb, R. A., & Sirrs, S. M. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00369-4 · Cited by 66
Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis
Härle, P., Pongratz, G., Weidler, C., Büttner, R., Schölmerich, J., & Straub, R. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011619 · Cited by 64
Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus.
Patavino, T., & Brady, D. M. (2001) · PubMed · Cited by 59
Prominent sex steroid metabolism in human lymphocytes
Zhou, Z., Shackleton, C. H. L., Pahwa, S. G., White, P. C., & Speiser, P. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00052-5 · Cited by 59
Novel therapeutic agents for systemic lupus erythematosus
Gescuk, B. D., & Davis, J. C. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00006 · Cited by 70
Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option
Bonam, S. R., Wang, F., & Muller, S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.009 · Cited by 55
Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus
Straub, R. H., Weidler, C., Demmel, B., Herrmann, M., Kees, F., Schmidt, M., Schölmerich, J., & Schedel, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014274 · Cited by 55
Dehydroepiandrosterone for the treatment of systemic lupus erythematosus
van Vollenhoven, R. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.1.23 · Cited by 54
Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus
Derksen, R. H. W. M. (1998) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(98)80013-9 · Cited by 55
OVERVIEW OF CELLULAR IMMUNE FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
Tsokos, G. C. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0053 · Cited by 54
Dehydroepiandrosterone for systemic lupus erythematosus
Crosbie, D., Black, C., McIntyre, L., Royle, P., & Thomas, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005114.pub2 · Cited by 54
Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects
Legrain, S., & Girard, L. (2003) · Drugs & Aging · doi:10.2165/00002512-200320130-00001 · Cited by 54
A Novel Dehydroepiandrosterone Analog Improves Functional Recovery in a Rat Traumatic Brain Injury Model
Malik, A. S., Narayan, R. K., Wendling, W. W., Cole, R. W., Pashko, L. L., Schwartz, A. G., & Strauss, K. I. (2003) · Journal of Neurotrauma · doi:10.1089/089771503765355531 · Cited by 53
The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects
Straub, R. H., Schuld, A., Mullington, J. M., Haack, M., Schölmerich, J., & Pollmächer, T. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750467 · Cited by 53
Androgen Supplementation in Older Women: Too Much Hype, Not Enough Data
Padero, M., Bhasin, S., & Friedman, T. C. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50273.x · Cited by 53
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial
Hartkamp, A., Geenen, R., Godaert, G. L. R., Bijl, M., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117036 · Cited by 51
Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus
Gordon, C., Wallace, D. J., Shinada, S., KALUNIAN, K. C., Forbess, L. J., Braunstein, G. D., & Weisman, M. H. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem342 · Cited by 50
Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study
Andus, T., Klebl, F. H., Rogler, G., Bregenzer, N., Schölmerich, J., & Straub, R. H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01433.x · Cited by 50
Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases - substitutes of adrenal and sex hormones
Straub, R. H., Schölmerich, J., & Zietz, B. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/pl00022854 · Cited by 47
Androgens indirectly accelerate thymocyte apoptosis
Dulos, G. J., & Bagchus, W. M. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00029-1 · Cited by 48
Interventions for cutaneous disease in systemic lupus erythematosus
Hannon, C. W., McCourt, C., Lima, H., Chen, S. C., & Bennett, C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007478.pub2 · Cited by 52
Lymphocytes Stimulate Dehydroepiandrosterone Production through Direct Cellular Contact with Adrenal Zona Reticularis Cells: A Novel Mechanism of Immune-Endocrine Interaction
Wolkersdörfer, G. W., Lohmann, T., Marx, C., Schröder, S., Pfeiffer, R., Hd, S., Scherbaum, W. A., Chrousos, G. P., & Bornstein, S. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6110 · Cited by 52
Correction for age of anticardiolipin antibodies cut-off points
Rapizzi, E., Ruffatti, A., Tonello, M., Piccoli, A., Calligaro, A., Sfriso, P., & TODESCO, S. (2000) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(2000)14:3 · Cited by 2
Dehydroepiandrosterone in systemic lupus erythematosus
Sawalha, A. H., & Kovats, S. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0046-1 · Cited by 44
Newer Drugs for the Treatment of Lupus Nephritis
Kuiper-Geertsma, D. G., & Derksen, R. H. W. M. (2003) · Drugs · doi:10.2165/00003495-200363020-00004 · Cited by 43
Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate
Valtýsdóttir, S. T., Wide, L., & Hallgren, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.875 · Cited by 42
The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies
Salek, F. S., Bigos, K. L., & Kroboth, P. D. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011274 · Cited by 40
The Importance of Systemic Cytokines in the Pathogenesis of Polymicrobial Sepsis and Dehydroepiandrosterone Treatment in a Rodent Model
Hildebrand, F., Pape, H., Hoevel, P., Krettek, C., & van Griensven, M. (2003) · Shock · doi:10.1097/01.shk.0000081408.57952.22 · Cited by 40
DHEA: A Biologist's Perspective
Hornsby, P. J. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02941.x · Cited by 41
Systemic Lupus Erythematosus
Petri, M. (2006) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000200420.67262.04 · Cited by 39
Treatment of systemic lupus erythematosus
Mosca, M., Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. V. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00037-6 · Cited by 40
The Use of Dehydroepiandrosterone Therapy in Clinical Practice
Cameron, D. R., & Braunstein, G. D. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504020-00004 · Cited by 38
DEHYDROEPIANDROSTERONE IN SYSTEMIC LUPUS ERYTHEMATOSUS
van Vollenhoven, R. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70142-3 · Cited by 36
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Bertsias, G. K., Ioannidis, J. P. A., Boletis, J. N., Bombardieri, S., Cervera, R., Dostál, C., Font, J., Gilboe, I.-M., Houssiau, F., Huizinga, T. W. J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083030 · Cited by 36
Is there a case for DHEA replacement?
Nippoldt, T. B., & Nair, K. S. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80286-3 · Cited by 36
Attenuation of house dust mite Dermatophagoides farinae‐induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down‐regulation of TH2 response
Yu, F., Yang, Y., Lei, L., Chen, Liu, Chen, & Liu (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00484.x · Cited by 35
Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?
Powrie, Y. S. L., & Smith, C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1324-0 · Cited by 36
NEW THERAPIES FOR SYSTEMIC LUPUS ERYTHEMATOSUS
Strand, V. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70145-9 · Cited by 32
Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus Erythematosus
Wiley, K. L., Treadwell, E. L., Manigaba, K., Word, B. R., & Lyn‐Cook, B. D. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9803-z · Cited by 32
Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus
Chang, D., Chu, S. J., Chen, H. C., Kuo, S. Y., & Lai, J. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016576 · Cited by 32
Regulation of Murine Interleukin-10 Production by Dehydroepiandrosterone
Cheng, G.-F., & Tseng, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050023889 · Cited by 30
Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus
o, L. C., pez-Longo, F. J. L., González, C. M., & Monteagudo, I. (2002) · Pediatric Drugs · doi:10.2165/00128072-200204040-00004 · Cited by 28
Dehydroepiandrosterone Response to the Adrenocorticotropin Test and the Combined Dexamethasone and Corticotropin-Releasing Hormone Test in Patients with Multiple Sclerosis
Kümpfel, T., Bergh, F. T., Frieß, E., Uhr, M., Yassouridis, A., Trenkwalder, C., & Holsboer, F. (1999) · Neuroendocrinology · doi:10.1159/000054505 · Cited by 26
Recognition and Management of Systemic Lupus Erythematosus
Schroeder, J. O., & Euler, H. H. (1997) · Drugs · doi:10.2165/00003495-199754030-00005 · Cited by 25
Autoimmunity, dehydroepiandrosterone (DHEA), and stress
Schwartz, K. E. (2002) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00385-8 · Cited by 25
Dehydroepiandrosterone Sulfate (DHEAS) and Testosterone: Relation to HIV Illness Stage and Progression Over One Year
Ferrando, S. J., Rabkin, J. G., & Poretsky, L. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199910010-00006 · Cited by 25
Update on emerging drug therapies for systemic lupus erythematosus
Mok, C. C. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903535878 · Cited by 23
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials
Yuen, S. Y., & Pope, J. E. (2008) · Rheumatology · doi:10.1093/rheumatology/ken230 · Cited by 23
Role of Androgen and Estrogen Receptors for the Action of Dehydroepiandrosterone (DHEA)
Engdahl, C., Lagerquist, M. K., Stubelius, A., Andersson, A., Studer, E., Ohlsson, C., Westberg, L., Carlsten, H., & Forsblad‐d’Elia, H. (2014) · Endocrinology · doi:10.1210/en.2013-1561 · Cited by 23
Exogenous Dehydroepiandrosterone Modified the Expression of T Helper-Related Cytokines in NZB/NZW F1 Mice
Yang, B.-C., Liu, C., Chen, Y. C., & Yu, C. (1998) · Immunological Investigations · doi:10.3109/08820139809070902 · Cited by 23
How accelerated atherosclerosis in SLE has changed our management of the disorder
Hallegua, D. S., & Wallace, D. J. (2000) · Lupus · doi:10.1191/096120300678828181 · Cited by 23
7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
Ginzler, E. M., & Aranow, C. B. (1998) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(98)80032-0 · Cited by 21
Dehydroepiandrosterone Therapy Ameliorates Experimental Autoimmune Myasthenia Gravis in Lewis Rats
Duan, R., Link, H., & Xiao, B. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1022572727408 · Cited by 21
Effects of Oral Prasterone (Dehydroepiandrosterone) on Single‐Dose Pharmacokinetics of Oral Prednisone and Cortisol Suppression in Normal Women
Tetang, G. M. L. M., Blum, R. A., Schwartz, K. E., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012742 · Cited by 21
Effects of Prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study
Marder, W., Somers, E. C., Kaplan, M. J., Anderson, M. D., Lewis, E., & McCune, W. J. (2010) · Lupus · doi:10.1177/0961203310371156 · Cited by 21
Primary Cultures of Human Synovial Macrophages Metabolize Androgensa
Cutolo, M., Villaggio, B., BARONE, A., Sulli, A., Accardo, S., Granata, O. M., & CASTAGNETTA, L. A. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16277.x · Cited by 21
Herbal and Related Remedies
Bartels, C. L., & Miller, S. J. (1998) · Nutrition in Clinical Practice · doi:10.1177/088453369801300102 · Cited by 21
Long-Term Administration of Intravaginal Dehydroepiandrosterone on Regression of Low-Grade Cervical Dysplasia – A Pilot Study
Suh‐Burgmann, E., Sivret, J., Duska, L., del Carmen, M., & Seiden, M. V. (2003) · Gynecologic and Obstetric Investigation · doi:10.1159/000068953 · Cited by 21
Systemic lupus erythematosus: modern strategies for management – a moving target
King, J. K., & Hahn, B. H. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.09.002 · Cited by 18
Treatment of systemic lupus erythematosus in 2006
Sibilia, J. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.09.003 · Cited by 20

Authors: Van Vollenhoven, R. F., Engleman, E. G., & Mcguire, J. L.
Affiliations: Stanford Medicine (US)
ORCID: Engleman, Edgar G.
Venue: Arthritis & Rheumatism
Publisher: Wiley
Published: 1995-12
Volume: 38
Issue: 12
Pages: 1826-1831
ISSN: 0004-3591 (ISSN-L)
1529-0131
DOI: 10.1002/art.1780381216
OpenAlex: W2070207717
Cited by: 192
References: 36
Citations by year: 2024: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2018: 3 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 5
FWCI: 5.90
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 3661 d)
Locations: Arthritis & Rheumatism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords: dehydroepiandrosterone, systemic lupus erythematosus, lupus flares, corticosteroid tapering, prednisone, SLEDAI, disease activity, acne, steroid-sparing therapy
MeSH terms: Adult, Dehydroepiandrosterone, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Lupus Erythematosus, Systemic, Prednisone, Severity of Illness Index, Chi-Square Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dehydroepiandrosterone in systemic lupus erythematosus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks